RxNorm 2105655 NDC Crossover

larotrectinib 25 MG Oral Capsule

Related NDC Codes to RxNorm Concept 2105655

The following NDC codes crossover to the RxNorm Concept 2105655. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
50419-390	Vitrakvi	Larotrectinib	Capsule	Oral	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
50419-391	Vitrakvi	Larotrectinib	Capsule	Oral	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
50419-392	Vitrakvi	Larotrectinib	Solution, Concentrate	Oropharyngeal	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
50419-393	Vitrakvi	Larotrectinib	Solution, Concentrate	Oropharyngeal	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
71777-390	Vitrakvi	Larotrectinib	Capsule	Oral	Loxo Oncology, Inc.	ACTIVE
71777-391	Vitrakvi	Larotrectinib	Capsule	Oral	Loxo Oncology, Inc.	ACTIVE
71777-392	Vitrakvi	Larotrectinib	Solution	Oral	Loxo Oncology, Inc.	ACTIVE